Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay
Woodford, R.; Barry, B.W.
Current Therapeutic Research 16(4): 338-345
1974
ISSN/ISBN: 0011-393X PMID: 4208350 Document Number: 77664
Document emailed within 1 workday
Related Documents
Stocchi, F. 1977: Clinical tests of topical preparations containing betamethasone 17-benzoate and the same associated with 5,7-dichloro-8-hydroxyquinoline (chloroxine) La Clinica Terapeutica 83(4): 359-369Sequira, J.; Berardi, M.; Chan, T.M.; Letarte, J.; Malchow, R.; Pramanick, B.; Wolkoff, H.N. 1991: Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment Clinical Therapeutics 13(6): 687-694
Lee, C.S.; Koo, J. 2009: The efficacy of three class i topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison Journal of Drugs in Dermatology: Jdd 8(8): 751-755
Gans, E.H.; Sadiq, I.; Stoudemayer, T.; Stoudemayer, M.; Kligman, A.M. 2008: In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle Journal of Drugs in Dermatology: Jdd 7(1): 28-32
Van Dijk, E.; Bakkers, E.J.; Go, M.J.; Montnor, L.P.; Roessel, F.E.; van der Wateren, A.R.; Wuite, J. 1983: Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream Cutis 32(3): 284-285; 287
Emer, J.J.; Frankel, A.; Sohn, A.; Lebwohl, M. 2011: A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis Journal of Drugs in Dermatology: Jdd 10(7): 735-743
Lapka, R.; Cepeláková, H.; Rejholec, V.; Franc, Z. 1986: Bioavailability of two oral formulations of triazolam using radioreceptor assay Die Pharmazie 41(4): 256-257
Nurse, D. 1978: Use of topical corticosteroid preparations Australian Family Physician 7(6): 683-684
Seth, B.L. 1992: Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel Arzneimittel-Forschung 42(2): 120-122
Singh, P.K.; Singh, G. 1985: Relative Potency of Topical Corticosteroid Preparations Indian Journal of Dermatology Venereology and Leprology 51(6): 309-312
Markiewicz, A.; Semenowicz, K.; Szczyrba, E.; Kocek, B. 1978: Comparison of bioavailability of two dipyridamole formulations Polish Journal of Pharmacology and Pharmacy 30(5): 605-609
Ortega, E.; Rodriguez, C.; Burdick, K.H.; Place, V.A.; Gonzales, L. 1971: The croton oil inflammation suppression assay as a measure of topical corticosteroid potency Acta Dermato-Venereologica. Supplementum 52(67): 95-97
Medansky, R.S.; Bressinck, R.; Cole, G.W.; Deeken, J.H.; Ellis, C.N.; Guin, J.D.; Herndon, J.H.; Lasser, A.E.; Leibsohn, E.; Menter, M.A. 1988: Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent Cutis 42(5): 480-485
Del Rosso, J.Q.; Kircik, L.H. 2013: The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream Journal of Drugs in Dermatology: Jdd 12(2): S5
Schmidt, P.C.; Kaupp, H. 1993: Stability and new formulations of hexetidine. 2. Formulations and in vitro bioavailability Die Pharmazie 48(11): 837-841
Terhaag, B.; Donath, F.; Le Petit, G.; Feller, K. 1986: The absolute and relative bioavailability of dipyridamole from different preparations and the in vitro-in vivo comparison International Journal of Clinical Pharmacology Therapy and Toxicology 24(6): 298-302
Gillet-Vanderbruggen, M. 1973: Evaluation of the activity of topical pharmaceuticals having a corticosteroid base Journal de Pharmacie de Belgique 28(5): 515-544
Gillet-Vanderbruggen, M. 1973: Evaluation of the activity of topical pharmaceuticals having a corticosteroid base Journal de Pharmacie de Belgique 28(5): 515-544
Woodbury, R.A.; Kligman, L.H.; Woodbury, M.J.; Kligman, A.M. 1994: Rapid assay of the anti-inflammatory activity of topical corticosteroids by inhibition of a UVA-induced neutrophil infiltration in hairless mouse skin. I. The assay and its sensitivity Acta Dermato-Venereologica 74(1): 15-17
Asawaworarit, P.; Chuanchaiyakul, S.; Kamanamool, N.; Piyavechvirat, T.; Udompataikul, M. 2017: The Comparative Study of Topical Therapy on Striae Alba between a Herbal Extract Cream and 0.1% Tretinoin Cream in Adolescence Journal of the Medical Association of Thailand 100(1): 93-99